Status:Closed
Opening date: 20 April 2026
Closing date: 1 June 2026
To encourage collaborative projects between MarMaRa Institute teams and patient associations, the Institute has launched a specific call for tenders for the first time in 2022. The aim is to strengthen links between research teams and patients through co-financing.
Each project is financed by the institute and the association, with a maximum of €10,000 for MarMaRa and an amount from the association equal to or greater than that of the institute (for example: €5,000 institute and €5,000 association; €7,000 institute and €7,000 association; €10,000 institute and €12,000 association). The maximum duration is 24 months.
| Year |
Title |
Partners |
Budget and duration |
Link to research team |
Link to the association |
|---|---|---|---|---|---|
| 2026 | Modeling Congenital Melanocytic Naevus Syndrome to discover vulnerable melanocytes progenitor states and therapeutics targets |
Chercheur :ETCHEVERS Heather, MMG Association : asonevus |
Budget : 4000€ Durée : 24 mois |
https://www.marseille-medical-genetics.org/fr/moped/ | asonevus |
| 2025 |
Oxytocin and breathing-induced heart rate variability in infants with Prader-Willi syndrome |
Chercheur : Thierry BRUE, MMG Association: Acromégales, pas seulement |
Budget : 6000€ Durée : 6 mois |
https://www.marseille-medical-genetics.org/fr/moped/ | Acromégalie |
| 2025 |
Early Detection of Acromegaly Using Artificial Intelligence from Hospital Medical Data: An Innovative Approach to Reduce Diagnostic Delay |
Chercheur : Françoise MUSCATELLI, INMED Association : Prader Willi France |
Budget : 10 000€ Durée : 12 mois |
https://www.inmed.fr/neurodeveloppement-et-syndrome-de-prader-willi | PWF |
| 2025 |
MATE Methylation Analysis in rare Tumors of Epidermal melanocytes |
Chercheur : Daniel ALDEA, MMG Association : Asonevus |
Budget : 12 000€ Durée : 18 mois |
https://www.marseille-medical-genetics.org/fr/h-etchevers/ | Asonevus |
| 2024 | New therapeutic perspectives for CCHS | This project is led by Jean-Charles Viemari (MMG laboratory) and the AFSO association. | Budget: €20,000 (€10,000 institute and €10,000 association) Duration: 18 months |
https://www.marseille-medical-genetics.org/fr/l-villard/ | AFSO |
| 2023 | Long read Sequencing to reduce diagnosis deadlocks in patients clinically diagnosed with FacioScapuloHumeral Dystrophy | This project is led by Frédérique Magdinier (MMG laboratory) and the AMIS FSH association. | Budget: €25,500 (€10,500 institute and €15,000 association) Duration: 24 months. |
https://www.marseille-medical-genetics.org/fr/f-magdinier/ | AMIS FSH |
| 2022 | Modelling Laminin a2-deficiency congenital muscular dystrophy using patients' pluripotent stem cells | This project is led by Leslie Caron (MMG laboratory) and the LAMA2France association. | Budget: €20,000 (€10,000 institute and €10,000 association) Duration: 24 months. |
https://www.marseille-medical-genetics.org/fr/f-magdinier/ | LAMA2 |
| 2022 | Spatial transcriptomic profiling of a rare somatic RASopathy | This project is led by Heather Etchevers (MMG laboratory) and the association Naevus 2000 France Europe. | Budget:€11,000 (€5,500 institute and €5,500 association) Duration: 12 months. |
https://www.marseille-medical-genetics.org/fr/h-etchevers/ | NAEVUS 2000 |
Documents
